Cetuximab
Records for this ingredient, by country (identity only).
ATC L01FE01 · 12 markets · 19 records
AU 5 records · 3 shown of 3
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 3 records · 3 shown of 3
- 100 mg/20 mLinjectionErbitux 100mg/50ml solution for infusion vials
- 500 mg/100 mLinjectionErbitux 100mg/50ml solution for infusion vials
- 100 mg/50 mLinjectionErbitux 100mg/50ml solution for infusion vials
US 2 records · 1 shown of 1
- 2 mg per mL / per unit basis not statedliquidERBITUX
CA 1 records · 1 shown of 1
- 2 mg per mL / per unit basis not statedliquidERBITUX
SG 1 records · 1 shown of 1
- 5 mg/mL per mL / per unit basis not statedinjectionErbitux 5mg/ml
CN 1 records · 1 shown of 1
- 100 mg/20 mLinjection爱必妥西妥昔单抗
ES 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionERBITUX
TW 1 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionErbitux 5mg/ml Solution for infusion爾必得舒 注射液 5 毫克/毫升
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 5 mg/1 mLinjectionERBITUX 5 mg/ml, solution pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg/20 mL injection | Erbitux 100mg/50ml solution for infusion vials | ERBITUX | 爱必妥西妥昔单抗 | ||||||||
| 5 mg per mL / per unit basis not stated cannot compare injection | ERBITUX | Erbitux 5mg/ml Solution for infusion 爾必得舒 注射液 5 毫克/毫升 | |||||||||
| 2 mg per mL / per unit basis not stated cannot compare liquid | ERBITUX | ERBITUX | |||||||||
| 500 mg/100 mL injection | Erbitux 100mg/50ml solution for infusion vials | ERBITUX | |||||||||
| 5 mg/mL per mL / per unit basis not stated cannot compare injection | ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion | Erbitux 5mg/ml | |||||||||
| 100 mg/50 mL injection | Erbitux 100mg/50ml solution for infusion vials | ||||||||||
| 5 mg/1 mL injection | ERBITUX 5 mg/ml, solution pour perfusion | ||||||||||
unknown | ERBITUX | ERBITUX SOLN FOR INFUSION 5MG/ML | ERBITUX |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in ES · TW · FR and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en ES · TW · FR que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 ES · TW · FR 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 ES · TW · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.